Omeros reported $85.68M in Equity Capital and Reserves for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Equity Capital And Reserves Change
Acelrx Pharmaceuticals ACRX:US USD 27.54M 5.6M
Adma Biologics ADMA:US USD 151.97M 51.59M
Alnylam Pharmaceuticals ALNY:US USD -158223000 90.58M
Biomarin Pharmaceutical BMRN:US USD 4.6B 34.64M
Cytokinetics CYTK:US USD -107900000 91.92M
Dynavax Technologies DVAX:US USD 581.01M 80.44M
Gilead Sciences GILD:US USD 21.21B 128M
Heron Therapeutics HRTX:US USD 13.57M 8.88M
Insmed INSM:US USD 87.95M 117.91M
Intercept Pharmaceuticals ICPT:US USD 93.08M 14.6M
Knight Therapeutics Inc GUD:CN CAD 825.86M 28.66M
Macrogenics MGNX:US USD 142.01M 19.06M
Mirati Therapeutics MRTX:US USD 996.52M 132.54M
Omeros OMER:US USD 85.68M 132M
Pacira Pharmaceuticals PCRX:US USD 775.01M 4.89M
Regulus Therapeutics RGLS:US USD 33.29M 6.38M
Rockwell Medical RMTI:US USD 16.14M 4.01M
Sangamo Biosciences SGMO:US USD 294.96M 14.2M
Sarepta Therapeutics SRPT:US USD 384.95M 45.89M
United Therapeutics UTHR:US USD 4.8B 234.5M
Vertex Pharmaceuticals VRTX:US USD 13.91B 883.1M
Vital Therapies VTL:US USD 113.68M 4.87M